KindlyMD (NAKA), a US-listed Bitcoin treasury company, announced on December 18 that its board has approved a share repurchase program. The initiative authorizes opportunistic buybacks of outstanding common stock, subject to market conditions and evolving regulatory considerations.

Repurchases may occur through open market transactions, privately negotiated deals, block trades, or other legally permissible means, and may be executed under a 10b5-1 trading plan, in compliance with Rule 10b-18 of the 1934 Securities Exchange Act.

Management will determine the timing, size, and method based on liquidity, share price, capital needs, and regulatory factors, and the board may amend, suspend, or terminate the program at any time; no fixed commitment to repurchase shares is required.

Previously, KindlyMD faced Nasdaq delisting risk after its stock traded below $1 for 30 consecutive days.